Literature DB >> 9343417

A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon.

E F Modafferi1, D L Black.   

Abstract

The mouse c-src gene contains a short neuron-specific exon, N1. To characterize the sequences that regulate N1 splicing, we used a heterologous gene, derived from the human beta-globin gene, containing a short internal exon that is usually skipped by the splicing machinery. Various fragments from the src gene were inserted into the globin substrate to measure their effects on the splicing of the test exon. These clones were transiently expressed in neuronal and nonneuronal cell lines, and the level of exon inclusion was measured by primer extension. Several sequences from the N1 exon region induced the splicing of the heterologous exon. The most powerful effect was seen with a sequence from the intron downstream of the N1 exon. This sequence acted as a strong splicing enhancer, activating splicing of the test exon when placed in the intron downstream. The enhancer was strongest in neuronal LA-N-5 cells but also activated splicing in nonneuronal HEK293 cells. Deletion and linker scanning mutagenesis indicate that the enhancer is made up of multiple smaller elements that must act in combination. One of these elements was identified as the sequence UGCAUG. Three copies of this element can strongly activate splicing of the test exon in LA-N-5 neuroblastoma cells. These component elements of the src splicing enhancer are also apparently involved in the splicing of other short cassette exons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343417      PMCID: PMC232507          DOI: 10.1128/MCB.17.11.6537

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

Review 1.  Alternative mRNA splicing.

Authors:  M McKeown
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Intronic sequence with both negative and positive effects on the regulation of alternative transcripts of the chicken beta tropomyosin transcripts.

Authors:  L Balvay; D Libri; M Gallego; M Y Fiszman
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

3.  Selection of splice sites in pre-mRNAs with short internal exons.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA.

Authors:  W P Dirksen; R K Hampson; Q Sun; F M Rottman
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

5.  Does steric interference between splice sites block the splicing of a short c-src neuron-specific exon in non-neuronal cells?

Authors:  D L Black
Journal:  Genes Dev       Date:  1991-03       Impact factor: 11.361

6.  A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon.

Authors:  M Caputi; G Casari; S Guenzi; R Tagliabue; A Sidoli; C A Melo; F E Baralle
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

7.  The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element.

Authors:  R Xu; J Teng; T A Cooper
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Polypurine sequences within a downstream exon function as a splicing enhancer.

Authors:  K Tanaka; A Watakabe; Y Shimura
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  The role of exon sequences in splice site selection.

Authors:  A Watakabe; K Tanaka; Y Shimura
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

10.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.

Authors:  J Y Wu; T Maniatis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

View more
  69 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Requirements for mini-exon inclusion in potato invertase mRNAs provides evidence for exon-scanning interactions in plants.

Authors:  C G Simpson; P E Hedley; J A Watters; G P Clark; C McQuade; G C Machray; J W Brown
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

3.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing.

Authors:  M Brudno; M S Gelfand; S Spengler; M Zorn; I Dubchak; J G Conboy
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

5.  Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.

Authors:  M J Simard; B Chabot
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 7.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

8.  U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA.

Authors:  Hui Zhu; Robert A Hasman; Katherine M Young; Nancy L Kedersha; Hua Lou
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitment.

Authors:  Shu-Ching Huang; Alexander C Ou; Jennie Park; Faye Yu; Brian Yu; Angela Lee; Guang Yang; Anyu Zhou; Edward J Benz
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

10.  A G-rich element forms a G-quadruplex and regulates BACE1 mRNA alternative splicing.

Authors:  Jean-François Fisette; Daniel R Montagna; Mihaela-Rita Mihailescu; Michael S Wolfe
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.